Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-v5vhk Total loading time: 0 Render date: 2024-07-06T16:58:32.910Z Has data issue: false hasContentIssue false

12 - Surgical Management (Resection)

from PART III - ORGAN-SPECIFIC CANCERS

Published online by Cambridge University Press:  18 May 2010

By
Brian D. Badgwell ,
Dario Ribero  and
Jean-Nicolas Vauthey
Edited by
Jean-François H. Geschwind  and
Michael C. Soulen
Brian D. Badgwell
Affiliation:
Surgical Oncology Fellow, Department of Surgical Oncology M.D. Anderson Cancer Center University of Texas Houston, TX
Dario Ribero
Affiliation:
Clinical Fellow, M.D. Anderson Cancer Center University of Texas Houston, TX
Jean-Nicolas Vauthey
Affiliation:
Professor of Surgery and Chief of the Liver Service, Department of Surgical Oncology M.D. Anderson Cancer Center University of Texas Houston, TX
Jean-François H. Geschwind
Affiliation:
The Johns Hopkins University School of Medicine
Michael C. Soulen
Affiliation:
University of Pennsylvania School of Medicine
Get access

Summary

Hepatocellular carcinoma (HCC) is the fifth most common neoplasm worldwide, affecting more than 600,000 people annually (1). Though less prevalent in the United States, the estimated annual number of cases exceeds 16,000. Moreover, despite a decline in alcoholic liver disease and increased use of hepatitis B immunization strategies, the incidence in our country is steadily rising and has doubled between 1975 and 1998, likely due to an increase in hepatitis C virus infection (2). In the majority of patients, HCC develops in fibrotic/cirrhotic livers, and cirrhosis represents the strongest predisposing factor.

The natural history of untreated HCC varies depending on the stage at presentation and the degree of underlying liver disease. However, even in patients with early stages, the prognosis is grim if the disease is left untreated (3, 4). As primary medical therapy has failed to significantly improve survival, surgical resection and orthotopic liver transplantation (OLT) represent the only treatment options, offering a prospect for cure with 5-year survival rates of up to 50% (5–7) and 70% (8, 9), respectively.

Unfortunately, only approximately 20% to 40% (10, 11) of patients are candidates for resection due to the burden of hepatic tumor, the presence of extrahepatic spread or the extent of underlying liver disease. Despite this, liver resections are increasingly being performed due to better perioperative care, improved imaging and advances in surgical technique.

Type
Chapter
Information
Interventional Oncology
Principles and Practice
 , pp. 121 - 134
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Parkin, D M, Bray, F, Ferlay, J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55(2): 74–108.CrossRefGoogle ScholarPubMed
El-Serag, H B, Mason, A C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340(10): 745–750.CrossRefGoogle ScholarPubMed
Nagasue, N, Yukaya, H, Hamada, T, et al. The natural history of hepatocellular carcinoma. A study of 100 untreated cases. Cancer 1984; 54(7): 1461–1465.3.0.CO;2-7>CrossRefGoogle ScholarPubMed
Barbara, L, Benzi, G, Gaiani, S, et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: A multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 1992; 16(1): 132–137.CrossRefGoogle ScholarPubMed
Shuto, T, Hirohashi, K, Kubo, S, et al. Changes and results of surgical strategies for hepatocellular carcinoma: Results of a 15-year study on 452 consecutive patients. Surg Today 1998; 28(11): 1124–1129.CrossRefGoogle ScholarPubMed
Zhou, X D, Tang, Z Y, Yang, B H, et al. Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer 2001; 91(8): 1479–1486.3.0.CO;2-0>CrossRefGoogle ScholarPubMed
Takenaka, K, Kawahara, N, Yamamoto, K, et al. Results of 280 liver resections for hepatocellular carcinoma. Arch Surg 1996; 131(1): 71–76.CrossRefGoogle ScholarPubMed
Mazzaferro, V, Regalia, E, Doci, R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334(11): 693–699.CrossRefGoogle ScholarPubMed
Llovet, J M, Bruix, J, Fuster, J, et al. Liver transplantation for small hepatocellular carcinoma: The tumor-node-metastasis classification does not have prognostic power. Hepatology 1998; 27(6): 1572–1577.CrossRefGoogle Scholar
Cance, W G, Stewart, A K, Menck, H R. The National Cancer Data Base Report on treatment patterns for hepatocellular carcinomas: Improved survival of surgically resected patients, 1985–1996. Cancer 2000; 88(4): 912–920.3.0.CO;2-T>CrossRefGoogle ScholarPubMed
Fong, Y, Sun, R L, Jarnagin, W, et al. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999; 229(6): 790–799.CrossRefGoogle Scholar
Belghiti, J, Hiramatsu, K, Benoist, S, et al. Seven hundred forty-seven hepatectomies in the 1990s: An update to evaluate the actual risk of liver resection. J Am Coll Surg 2000; 191(1): 38–46.CrossRefGoogle ScholarPubMed
Wei, A C, Tung-Ping Poon, R, Fan, S T, et al. Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg 2003; 90(1): 33–41.CrossRefGoogle ScholarPubMed
Pugh, R N, Murray-Lyon, I M, Dawson, J L, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60(8): 646–649.CrossRefGoogle ScholarPubMed
Mansour, A, Watson, W, Shayani, V, et al. Abdominal operations in patients with cirrhosis: Still a major surgical challenge. Surgery 1997; 122(4): 730–735.CrossRefGoogle Scholar
Teh, S H, Christein, J, Donohue, J, et al. Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality. J Gastrointest Surg 2005; 9(9): 1207–1215.CrossRefGoogle ScholarPubMed
Belghiti, J, Regimbeau, J M, Durand, F, et al. Resection of hepatocellular carcinoma: A European experience on 328 cases. Hepatogastroenterology 2002; 49(43): 41–46.Google ScholarPubMed
Fan, S T, Lo, C M, Liu, C L, et al. Hepatectomy for hepatocellular carcinoma: Toward zero hospital deaths. Ann Surg 1999; 229(3): 322–330.CrossRefGoogle ScholarPubMed
Bruix, J, Castells, A, Bosch, J, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: Prognostic value of preoperative portal pressure. Gastroenterology 1996; 111(4): 1018–1022.CrossRefGoogle ScholarPubMed
Eguchi, H, Umeshita, K, Sakon, M, et al. Presence of active hepatitis associated with liver cirrhosis is a risk factor for mortality caused by posthepatectomy liver failure. Dig Dis Sci 2000; 45(7): 1383–1388.CrossRefGoogle ScholarPubMed
Haber, M M, West, A B, Haber, A D, et al. Relationship of aminotransferases to liver histological status in chronic hepatitis C. Am J Gastroenterol 1995; 90(8): 1250–1257.Google ScholarPubMed
Healey, C J, Chapman, R W, Fleming, K A. Liver histology in hepatitis C infection: A comparison between patients with persistently normal or abnormal transaminases. Gut 1995; 37(2): 274–278.CrossRefGoogle ScholarPubMed
Poon, R T, Fan, S T, Lo, C M, et al. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. J Clin Oncol 2000; 18(5): 1094–1101.CrossRefGoogle ScholarPubMed
Noun, R, Jagot, P, Farges, O, et al. High preoperative serum alanine transferase levels: Effect on the risk of liver resection in Child grade A cirrhotic patients. World J Surg 1997; 21(4): 390–394.CrossRefGoogle Scholar
Torzilli, G, Makuuchi, M, Inoue, K, et al. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: Is there a way? A prospective analysis of our approach. Arch Surg 1999; 134(9): 984–992.CrossRefGoogle Scholar
Abdalla, E K, Denys, A, Chevalier, P, et al. Total and segmental liver volume variations: Implications for liver surgery. Surgery 2004; 135(4): 404–410.CrossRefGoogle ScholarPubMed
Kawasaki, T, Moriyasu, F, Kimura, T, et al. Changes in portal blood flow consequent to partial hepatectomy: Doppler estimation. Radiology 1991; 180(2): 373–377.CrossRefGoogle ScholarPubMed
Panis, Y, McMullan, D M, Emond, J C. Progressive necrosis after hepatectomy and the pathophysiology of liver failure after massive resection. Surgery 1997; 121(2): 142–149.CrossRefGoogle ScholarPubMed
Vauthey, J N, Abdalla, E K, Doherty, D A, et al. Body surface area and body weight predict total liver volume in Western adults. Liver Transpl 2002; 8(3): 233–240.CrossRefGoogle ScholarPubMed
Abdalla, E K, Hicks, M E, Vauthey, J N. Portal vein embolization: Rationale, technique and future prospects. Br J Surg 2001; 88(2): 165–175.CrossRefGoogle ScholarPubMed
Johnson, T N, Tucker, G T, Tanner, M S, et al. Changes in liver volume from birth to adulthood: A meta-analysis. Liver Transpl 2005; 11(12): 1481–1493.CrossRefGoogle ScholarPubMed
Abdalla, E K, Barnett, C C, Doherty, D, et al. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 2002; 137(6): 675–680.CrossRefGoogle ScholarPubMed
Shirabe, K, Shimada, M, Gion, T, et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg 1999; 188(3): 304–309.CrossRefGoogle ScholarPubMed
Kokudo, N, Makuuchi, M. Current role of portal vein embolization/hepatic artery chemoembolization. Surg Clin North Am 2004; 84(2): 643–657.CrossRefGoogle ScholarPubMed
Ijichi, M, Makuuchi, M, Imamura, H, et al. Portal embolization relieves persistent jaundice after complete biliary drainage. Surgery 2001; 130(1): 116–118.CrossRefGoogle ScholarPubMed
Hirai, I, Kimura, W, Fuse, A, et al. Evaluation of preoperative portal embolization for safe hepatectomy, with special reference to assessment of nonembolized lobe function with 99mTc-GSA SPECT scintigraphy. Surgery 2003; 133(5): 495–506.CrossRefGoogle ScholarPubMed
Vauthey, J N, Chaoui, A, Do, K A, et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 2000; 127(5): 512–519.CrossRefGoogle ScholarPubMed
Farges, O, Belghiti, J, Kianmanesh, R, et al. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 2003; 237(2): 208–217.CrossRefGoogle ScholarPubMed
Kokudo, N, Bandai, Y, Imanishi, H, et al. Management of new hepatic nodules detected by intraoperative ultrasonography during hepatic resection for hepatocellular carcinoma. Surgery 1996; 119(6): 634–640.CrossRefGoogle ScholarPubMed
Takigawa, Y, Sugawara, Y, Yamamoto, J, et al. New lesions detected by intraoperative ultrasound during liver resection for hepatocellular carcinoma. Ultrasound Med Biol 2001; 27(2): 151–156.CrossRefGoogle ScholarPubMed
Torzilli, G, Makuuchi, M. Intraoperative ultrasonography in liver cancer. Surg Oncol Clin North Am 2003; 12(1): 91–103.CrossRefGoogle ScholarPubMed
Lau, W Y, Leung, K L, Lee, T W, et al. Ultrasonography during liver resection for hepatocellular carcinoma. Br J Surg 1993; 80(4): 493–494.CrossRefGoogle ScholarPubMed
Hasegawa, K, Kokudo, N, Imamura, H, et al. Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg 2005; 242(2): 252–259.CrossRefGoogle ScholarPubMed
Regimbeau, J M, Kianmanesh, R, Farges, O, et al. Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma. Surgery 2002; 131(3): 311–317.CrossRefGoogle ScholarPubMed
Poon, R T, Fan, S T, Ng, I O, et al. Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal. Ann Surg 2000; 231(4): 544–551.CrossRefGoogle ScholarPubMed
Jwo, S C, Chiu, J H, Chau, G Y, et al. Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection. Hepatology 1992; 16(6): 1367–1371.CrossRefGoogle ScholarPubMed
Yamamoto, J, Kosuge, T, Takayama, T, et al. Recurrence of hepatocellular carcinoma after surgery. Br J Surg 1996; 83(9): 1219–1222.CrossRefGoogle ScholarPubMed
Cha, C H, Ruo, L, Fong, Y, et al. Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation. Ann Surg 2003; 238(3): 315–321; discussion 21–23.Google ScholarPubMed
Man, K, Fan, S T, Ng, I O, et al. Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg 1997; 226(6): 704–711.CrossRefGoogle ScholarPubMed
Belghiti, J, Noun, R, Malafosse, R, et al. Continuous versus intermittent portal triad clamping for liver resection: A controlled study. Ann Surg 1999; 229(3): 369–375.CrossRefGoogle ScholarPubMed
Belghiti, J, Noun, R, Zante, E, et al. Portal triad clamping or hepatic vascular exclusion for major liver resection: A controlled study. Ann Surg 1996; 224(2): 155–161.Google ScholarPubMed
Torzilli, G, Makuuchi, M, Midorikawa, Y, et al. Liver resection without total vascular exclusion: Hazardous or beneficial? An analysis of our experience. Ann Surg 2001; 233(2): 167–175.CrossRefGoogle ScholarPubMed
Lortat-Jacob, J L, Robert, H G, Henry, C. Excision of the right lobe of the liver for a malignant secondary tumor. Arch Mal Appar Dig Mal Nutr 1952; 41(6): 662–667.Google ScholarPubMed
Johnson, M, Mannar, R, Wu, A V. Correlation between blood loss and inferior vena caval pressure during liver resection. Br J Surg 1998; 85(2): 188–190.CrossRefGoogle ScholarPubMed
Rees, M, Plant, G, Wells, J, et al. One hundred and fifty hepatic resections: Evolution of technique towards bloodless surgery. Br J Surg 1996; 83(11): 1526–1529.CrossRefGoogle ScholarPubMed
Cunningham, J D, Fong, Y, Shriver, C, et al. One hundred consecutive hepatic resections: Blood loss, transfusion, and operative technique. Arch Surg 1994; 129(10): 1050–1056.CrossRefGoogle ScholarPubMed
Aloia, T A, Zorzi, D, Abdalla, E K, et al. Two-surgeon technique for hepatic parenchymal transection of the noncirrhotic liver using saline-linked cautery and ultrasonic dissection. Ann Surg 2005; 242(2): 172–177.CrossRefGoogle ScholarPubMed
Petrowsky, H, Demartines, N, Rousson, V, et al. Evidence-based value of prophylactic drainage in gastrointestinal surgery: A systematic review and meta-analyses. Ann Surg 2004; 240(6): 1074–1084.CrossRefGoogle ScholarPubMed
Liu, C L, Fan, S T, Lo, C M, et al. Abdominal drainage after hepatic resection is contraindicated in patients with chronic liver diseases. Ann Surg 2004; 239(2): 194–201.CrossRefGoogle ScholarPubMed
Foster, J H, Berman, M M. Solid Liver TumorsPhiladelphia: W. B. Saunders Company 1977.Google ScholarPubMed
Jaeck, D, Bachellier, P, Oussoultzoglou, E, et al. Surgical resection of hepatocellular carcinoma. Post-operative outcome and long-term results in Europe: An overview. Liver Transpl 2004; 10(2 Suppl 1): S58–63.CrossRefGoogle ScholarPubMed
Makuuchi, M, Takayama, T, Gunven, P, et al. Restrictive versus liberal blood transfusion policy for hepatectomies in cirrhotic patients. World J Surg 1989; 13(5): 644–648.CrossRefGoogle ScholarPubMed
Shimada, M, Takenaka, K, Fujiwara, Y, et al. Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma. Br J Surg 1998; 85(2): 195–198.CrossRefGoogle ScholarPubMed
Bismuth, H, Majno, P, Adam, R. Hepatocellular carcinoma: From ethanol injection to liver transplantation. Acta Gastroenterologica Belgica 1999; 62(3): 330–341.Google ScholarPubMed
Capussotti, L, Borgonovo, G, Bouzari, H, et al. Results of major hepatectomy for large primary liver cancer in patients with cirrhosis. Br J Surg 1994; 81(3): 427–431.CrossRefGoogle ScholarPubMed
Belghiti, J, Panis, Y, Farges, O, et al. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 1991; 214(2): 114–117.CrossRefGoogle ScholarPubMed
Nagasue, N, Kohno, H, Chang, Y C, et al. Liver resection for hepatocellular carcinoma: Results of 229 consecutive patients during 11 years. Ann Surg 1993; 217(4): 375–384.CrossRefGoogle ScholarPubMed
Liver Cancer Study Group of Japan. Predictive factors for long-term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 1994; (74): 2272–2780.
Liver (including intrahepatic bile ducts). In Greene, F L, Page, D L, Fleming, I D., eds: American Joint Committee on Cancer Staging Manual, 6th Edition, pp. 131–144. New York, NY: Springer-Verlag 2002.CrossRefGoogle Scholar
Vauthey, J N, Lauwers, G Y, Esnaola, N F, et al. Simplified staging for hepatocellular carcinoma. J Clin Oncol 2002; 20(6): 1527–1536.CrossRefGoogle ScholarPubMed
Izumi, R, Shimizu, K, Ii, T, et al. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 1994; 106(3): 720–727.CrossRefGoogle ScholarPubMed
Vauthey, J N, Klimstra, D, Franceschi, D, et al. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 1995; 169(1): 28–34.CrossRefGoogle ScholarPubMed
Tsai, T J, Chau, G Y, Lui, W Y, et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 2000; 127(6): 603–608.CrossRefGoogle ScholarPubMed
Poon, R T, Fan, S T. Evaluation of the new AJCC/UICC staging system for hepatocellular carcinoma after hepatic resection in Chinese patients. Surg Oncol Clin North Am 2003; 12(1): 35–50, viii.CrossRefGoogle ScholarPubMed
Ramacciato, G, Mercantini, P, Cautero, N, et al. Prognostic evaluation of the new American Joint Committee on Cancer/International Union Against Cancer staging system for hepatocellular carcinoma: Analysis of 112 cirrhotic patients resected for hepatocellular carcinoma. Ann Surg Oncol 2005; 12(4): 289–297.CrossRefGoogle ScholarPubMed
Lai, E C, Ng, I O, You, K T, et al. Hepatic resection for small hepatocellular carcinoma: The Queen Mary Hospital experience. World J Surg 1991; 15(5): 654–659.CrossRefGoogle ScholarPubMed
Kanematsu, T, Takenaka, K, Matsumata, T, et al. Limited hepatic resection effective for selected cirrhotic patients with primary liver cancer. Ann Surg 1984; 199(1): 51–56.CrossRefGoogle ScholarPubMed
Nagasue, N, Yukaya, H, Ogawa, Y, et al. Clinical experience with 118 hepatic resections for hepatocellular carcinoma. Surgery 1986; 99(6): 694–701.Google ScholarPubMed
Pawlik, T M, Delman, K A, Vauthey, J N, et al. Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 2005; 11(9): 1086–1092.CrossRefGoogle ScholarPubMed
Llovet, J M, Bustamante, J, Castells, A, et al. Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials. Hepatology 1999; 29(1): 62–67.CrossRefGoogle ScholarPubMed
Poon, R T, Fan, S T, Lo, C M, et al. Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: Is it justified?Ann Surg 2002; 236(5): 602–611.CrossRefGoogle ScholarPubMed
Pawlik, T M, Poon, R T, Abdalla, E K, et al. Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Arch Surg 2005; 140(5): 450–457.CrossRefGoogle ScholarPubMed
Llovet, J M, Bru, C, Bruix, J. Prognosis of hepatocellular carcinoma: The BCLC staging classification. Semin Liver Dis 1999; 19(3): 329–338.CrossRefGoogle ScholarPubMed
Bruix, J, Llovet, J M. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002; 35(3): 519–524.CrossRefGoogle ScholarPubMed
Minagawa, M, Makuuchi, M, Takayama, T, et al. Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg 2001; 233(3): 379–384.CrossRefGoogle ScholarPubMed
Pawlik, T M, Poon, R T, Abdalla, E K, et al. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: Results of a multicenter study. Surgery 2005; 137(4): 403–410.CrossRefGoogle ScholarPubMed
Bruix, J, Sherman, M. Management of hepatocellular carcinoma. Hepatology 2005; 42(5): 1208–1236.CrossRefGoogle ScholarPubMed
Ng, K K, Vauthey, J N, Pawlik, T M, et al. Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol 2005; 12(5): 364–373.CrossRefGoogle ScholarPubMed
Wu, C C, Ho, W L, Lin, M C, et al. Hepatic resection for bilobar multicentric hepatocellular carcinoma: Is it justified?Surgery 1998; 123(3): 270–277.CrossRefGoogle ScholarPubMed
Hui, A M, Takayama, T, Sano, K, et al. Predictive value of gross classification of hepatocellular carcinoma on recurrence and survival after hepatectomy. J Hepatol 2000; 33(6): 975–979.CrossRefGoogle ScholarPubMed
Nagao, T, Inoue, S, Goto, S, et al. Hepatic resection for hepatocellular carcinoma: Clinical features and long-term prognosis. Ann Surg 1987; 205(1): 33–40.CrossRefGoogle ScholarPubMed
Matsumoto, Y, Fujii, H, Matsuda, M, et al. Multicentric occurrence of hepatocellular carcinoma: Diagnosis and clinical significance. J Hepatobiliary Pancreat Surg 2001; 8(5): 435–440.CrossRefGoogle ScholarPubMed
Bilimoria, M M, Lauwers, G Y, Doherty, D A, et al. Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. Arch Surg 2001; 136(5): 528–535.CrossRefGoogle Scholar
Vauthey, J N, Walsh, G L, Vlastos, G, et al. Importance of field cancerisation in clinical oncology. The Lancet Oncology 2000; 1(1): 15–16.CrossRefGoogle ScholarPubMed
Ishak, K, Baptista, A, Bianchi, L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22(6): 696–699.CrossRefGoogle ScholarPubMed
Suenaga, M, Sugiura, H, Kokuba, Y, et al. Repeated hepatic resection for recurrent hepatocellular carcinoma in eighteen cases. Surgery 1994; 115(4): 452–457.Google ScholarPubMed
Kakazu, T, Makuuchi, M, Kawasaki, S, et al. Repeat hepatic resection for recurrent hepatocellular carcinoma. Hepatogastroenterology 1993; 40(4): 337–341.Google ScholarPubMed
Matsuda, Y, Ito, T, Oguchi, Y, et al. Rationale of surgical management for recurrent hepatocellular carcinoma. Ann Surg 1993; 217(1): 28–34.CrossRefGoogle ScholarPubMed
Shimada, M, Takenaka, K, Taguchi, K, et al. Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg 1998; 227(1): 80–85.CrossRefGoogle ScholarPubMed
Arii, S, Monden, K, Niwano, M, et al. Results of surgical treatment for recurrent hepatocellular carcinoma: Comparison of outcome among patients with multicentric carcinogenesis, intrahepatic metastasis, and extrahepatic recurrence. J Hepatobiliary Pancreat Surg 1998; 5(1): 86–92.CrossRefGoogle ScholarPubMed
Minagawa, M, Makuuchi, M, Takayama, T, et al. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 2003; 238(5): 703–710.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Surgical Management (Resection)
    • By Brian D. Badgwell, Surgical Oncology Fellow, Department of Surgical Oncology M.D. Anderson Cancer Center University of Texas Houston, TX, Dario Ribero, Clinical Fellow, M.D. Anderson Cancer Center University of Texas Houston, TX, Jean-Nicolas Vauthey, Professor of Surgery and Chief of the Liver Service, Department of Surgical Oncology M.D. Anderson Cancer Center University of Texas Houston, TX
  • Edited by Jean-François H. Geschwind, The Johns Hopkins University School of Medicine, Michael C. Soulen, University of Pennsylvania School of Medicine
  • Book: Interventional Oncology
  • Online publication: 18 May 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511722226.013
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Surgical Management (Resection)
    • By Brian D. Badgwell, Surgical Oncology Fellow, Department of Surgical Oncology M.D. Anderson Cancer Center University of Texas Houston, TX, Dario Ribero, Clinical Fellow, M.D. Anderson Cancer Center University of Texas Houston, TX, Jean-Nicolas Vauthey, Professor of Surgery and Chief of the Liver Service, Department of Surgical Oncology M.D. Anderson Cancer Center University of Texas Houston, TX
  • Edited by Jean-François H. Geschwind, The Johns Hopkins University School of Medicine, Michael C. Soulen, University of Pennsylvania School of Medicine
  • Book: Interventional Oncology
  • Online publication: 18 May 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511722226.013
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Surgical Management (Resection)
    • By Brian D. Badgwell, Surgical Oncology Fellow, Department of Surgical Oncology M.D. Anderson Cancer Center University of Texas Houston, TX, Dario Ribero, Clinical Fellow, M.D. Anderson Cancer Center University of Texas Houston, TX, Jean-Nicolas Vauthey, Professor of Surgery and Chief of the Liver Service, Department of Surgical Oncology M.D. Anderson Cancer Center University of Texas Houston, TX
  • Edited by Jean-François H. Geschwind, The Johns Hopkins University School of Medicine, Michael C. Soulen, University of Pennsylvania School of Medicine
  • Book: Interventional Oncology
  • Online publication: 18 May 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511722226.013
Available formats
×